Microsoft Research introduced Quine on September 29, an experimental system that connects genomic, protein, chemical, cell-state and imaging data. The company says the aim is to help researchers use computation to rank hypotheses before committing scarce laboratory time and samples to physical experiments.
According to Microsoft's primary announcement, the system was tested with Broad Institute researchers on pancreatic-cancer cell states. Several compounds prioritised by Quine moved cells in the expected direction in laboratory assays. This is a research result, not clinical evidence: Quine is not intended for diagnosis or treatment, and its outputs require expert review and experimental validation.
For Hungarian biotechnology and university laboratories, the relevant signal is the model of shared access to research infrastructure and computing capacity. Access remains limited. Applications for the first 16-week Quine Fellows cohort close on November 2, while the programme is scheduled to begin in June 2027.
Related coverage includes Apple's tighter access controls for AI agents and Google's restricted cybersecurity rollout of Gemini 4 Argon.
Original editorial content. Read our editorial standards.
Budapest Global Review: Microsoft opens experimental biology AI system. Budapest Global Review, 29 September 2026. https://globalreview.hu/en/cikk/microsoft-quine-biologiai-mi-rendszer-2026